Clinical Trial Update: Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 safety and tolerability study evaluated rituximab with methotrexate plus either etanercept or adalimumab in active rheumatoid arthritis; the trial was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• Humira (adalimumab)
• METHOTREXATE (METHOTREXATE)
• Rituxan (rituximab)

Snippet

Sponsor: Biogen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2010-11-17